01Jun 2022
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort

Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort

The study presents preliminary safety and efficacy data from the initial roll‐in cohort of the REBALANCE‐HF trial. The open‐label (roll‐in) arm of REBALANCE‐HF will enrol up to 30 patients, followed by the randomized, sham‐controlled portion of the trial. The preliminary open‐label results from the multicentre REBALANCE‐HF roll‐in cohort support the safety and efficacy of SAVM in HFpEF. However, the findings require confirmation in the trial's ongoing randomized, sham‐controlled portion.

  • #cardiology

Like

Save

Share